# Novo Nordisk

> <p><strong>Known for:</strong> The GLP-1 medicines Ozempic, which controls type 2 diabetes, and Wegovy, which drives major weight loss in obesity, built on a century of insulin production.<br><strong>Employees:</strong> ~78,000</p>

![Novo](https://euronomy.eu/media/xd5owks2/novo.png)

Novo Nordisk is a Danish company headquartered in Bagsvaerd, focused on diabetes, obesity, endocrinology and rare diseases, and a cornerstone of the Danish economy. Its GLP-1 medicines Ozempic and Wegovy reshaped the treatment of diabetes and obesity.

Facing intense competition from Eli Lilly, Novo Nordisk announced around 9,000 job cuts in 2025 under a new chief executive as part of a major restructuring.

https://www.novonordisk.com